[AVHN-577](https://amalgamrx.atlassian.net/browse/AVHN-577) : Change logo for Eylea HD on the portal
[AVHN-553](https://amalgamrx.atlassian.net/browse/AVHN-553) : Changes to MMIT Api calls
[AVHN-546](https://amalgamrx.atlassian.net/browse/AVHN-546) : [PROD] Regeneron Production Release.
[AVHN-538](https://amalgamrx.atlassian.net/browse/AVHN-538) : Regeneron: Add Support for completing MMIT coverage check using a policy number of patient
[AVHN-517](https://amalgamrx.atlassian.net/browse/AVHN-517) : Regeneron: Add support for completing MMIT coverage check for a site by using a group number of patient
[AVHN-490](https://amalgamrx.atlassian.net/browse/AVHN-490) : Regeneron: Need to update the Email subject for EYLEA-NOW
[AVHN-480](https://amalgamrx.atlassian.net/browse/AVHN-480) : Regeneron: Change Indication Names as per RC feedback
[AVHN-455](https://amalgamrx.atlassian.net/browse/AVHN-455) : Update Intended use to inlcude both Eylea Drugs.
[AVHN-444](https://amalgamrx.atlassian.net/browse/AVHN-444) : Regeneron: Add Safety Information Link in Menu on EYLEA-NOW
[AVHN-438](https://amalgamrx.atlassian.net/browse/AVHN-438) : Regeneron UI Updates based on RC review
[AVHN-436](https://amalgamrx.atlassian.net/browse/AVHN-436) : Regeneron: Update Language in Intended Use and Disclaimer.
[AVHN-435](https://amalgamrx.atlassian.net/browse/AVHN-435) : Regeneron: Remove Macular Edema Following RVO for Eylea HD
[AVHN-425](https://amalgamrx.atlassian.net/browse/AVHN-425) : Create Compatibility test protocol document
[AVHN-420](https://amalgamrx.atlassian.net/browse/AVHN-420) : Verification Tasks
[AVHN-419](https://amalgamrx.atlassian.net/browse/AVHN-419) : iFrame overlapping issue in Firefox Browser
[AVHN-418](https://amalgamrx.atlassian.net/browse/AVHN-418) : New product Id for Eylea HD 8mg is 252886
[AVHN-417](https://amalgamrx.atlassian.net/browse/AVHN-417) : Regeneron Team feedback - Change the order of the appearance of Logos and the Tabs. To be: EYLEA HD followed by EYLEA 2mg
[AVHN-411](https://amalgamrx.atlassian.net/browse/AVHN-411) : [Utilities] Update amalgam_web_utils to use latest RDS cert in all regeneron repos
[AVHN-407](https://amalgamrx.atlassian.net/browse/AVHN-407) : [Client] Logo change
[AVHN-398](https://amalgamrx.atlassian.net/browse/AVHN-398) : Regeneron: Support for MMIT Fields For 2mg and 8mg drug
[AVHN-379](https://amalgamrx.atlassian.net/browse/AVHN-379) : pre production Activities
[AVHN-374](https://amalgamrx.atlassian.net/browse/AVHN-374) : Update 2mg logo for EYLEA-NOW as the logo has changed from Regeneron side.  
[AVHN-373](https://amalgamrx.atlassian.net/browse/AVHN-373) : Adding the deleted API tests after Caremetx API issue resolved
[AVHN-355](https://amalgamrx.atlassian.net/browse/AVHN-355) : Login URL issue
[AVHN-344](https://amalgamrx.atlassian.net/browse/AVHN-344) : Validation - Eylea-Now V1.1
[AVHN-343](https://amalgamrx.atlassian.net/browse/AVHN-343) : Update the api to match with the changes made by caremetx's enrollment details API
[AVHN-335](https://amalgamrx.atlassian.net/browse/AVHN-335) : Practice payload created in initiateMedBV and initiateMedPA API call must correspond to patient's department ID only.
[AVHN-328](https://amalgamrx.atlassian.net/browse/AVHN-328) : Eylea-Now Standalone login Flow
[AVHN-316](https://amalgamrx.atlassian.net/browse/AVHN-316) : Update EYLEA-NOW user guide
[AVHN-313](https://amalgamrx.atlassian.net/browse/AVHN-313) : Provider details to updated for a Patient if provider has been updated in the EHR system
[AVHN-312](https://amalgamrx.atlassian.net/browse/AVHN-312) : [Regeneron] Migrate mui v4 -> v5
[AVHN-309](https://amalgamrx.atlassian.net/browse/AVHN-309) : Layout refactor
[AVHN-302](https://amalgamrx.atlassian.net/browse/AVHN-302) : Column width issue
Total number of issues found: 33
